We are live on ! Find out more
MTNB icon

Matinas BioPharma

45 hedge funds and large institutions have $8.74M invested in Matinas BioPharma in 2018 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 14 increasing their positions, 7 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 7

36% more capital inflows, than outflows

Capital inflows: $778K | Capital outflows: $574K

0.03% more ownership

Funds ownership: 12.02% → 12.05% (+0.03%)

8% less funds holding

Funds holding: 49 → 45 (-4)

33% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 9

Holders
45
Holders Change
-4
Holders Change %
-8.16%
% of All Funds
1.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
14
Reduced
7
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

MTNB Hedge Fund Activity: Q1 2018 in Review

45 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Matinas BioPharma (MTNB) for Q1 2018, worth a combined $8.74M — down 33% from $13M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of MTNB and 6 opened new positions — a net loss of 3 holders — while 7 trimmed existing stakes and 14 added.

The largest buyer was Royal Bank of Canada, adding an estimated $476K. The largest seller was American Century Companies, exiting entirely with an estimated $155K sold.

  • 45 institutional investors held Matinas BioPharma (MTNB) as of Q1 2018, down from 49 in Q4 2017.
  • Funds reported $8.74M of Matinas BioPharma stock for Q1 2018, down 33% quarter-over-quarter.
  • 6 funds opened new Matinas BioPharma positions in Q1 2018 and 9 closed out, a net change of -3 holders.
  • The largest Matinas BioPharma buyer in Q1 2018 was Royal Bank of Canada, an estimated $476K added.
  • The largest Matinas BioPharma seller in Q1 2018 was American Century Companies, an estimated $155K sold.

Based on aggregated 13F filings for Q1 2018.